Huiyu Pharmaceuticals: Net loss of 24.2002 million yuan in 2025

2026-03-30 13:08:42

Huiyu Pharmaceutical releases a performance quick report. In 2025, it achieved total operating revenue of RMB 998 million, a year-on-year decrease of 8.79%; net profit was a loss of RMB 24.2002 million, compared with net profit of RMB 325 million in the same period last year. During the reporting period, the centralized procurement program continued to deepen. The company actively implemented the national centralized volume-based procurement policy; the prices and profits of relevant products declined, which affected the company’s performance.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.